Anna Lucia Cannarozzi, Anna Latiano, Luca Massimino, Fabrizio Bossa, Francesco Giuliani, Matteo Riva, Federica Ungaro, Maria Guerra, Anna Laura Di Brina, Giuseppe Biscaglia, Francesca Tavano, Sonia Carparelli, Gionata Fiorino, Silvio Danese, Francesco Perri, Orazio Palmieri
Various extrinsic and intrinsic factors such as drug exposures, antibiotic treatments, smoking, lifestyle, genetics, immune responses, and the gut microbiome characterize ulcerative colitis and Crohn's disease, collectively called inflammatory bowel disease (IBD). All these factors contribute to the complexity and heterogeneity of the disease etiology and pathogenesis leading to major challenges for the scientific community in improving management, medical treatments, genetic risk, and exposome impact. Understanding the interaction(s) among these factors and their effects on the immune system in IBD patients has prompted advances in multi-omics research, the development of new tools as part of system biology, and more recently, artificial intelligence (AI) approaches...
August 31, 2024: United European Gastroenterology Journal